Article
Protein-truncating and rare missense variants in ATM and CHEK2 and associations with cancer in UK Biobank whole-exome sequence data.
Journal of medical genetics - 23 Oct 2024
Mukhtar Toqir K, Wilcox Naomi, Dennis Joe, Yang Xin, Naven Marc, Mavaddat Nasim, Perry John R B, Gardner Eugene, Easton Douglas F
Abstract excerpt
BACKGROUND: Deleterious germline variants in ATM and CHEK2 have been associated with a moderately increased risk of breast cancer. Risks for other cancers remain unclear. METHODS: Cancer associations for coding variants in ATM and CHEK2 were evaluated using whole-exome sequence data from UK Biobank linked to cancer registration data (348 488 participants), and analysed both as a retrospective case-control and a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
